Modulation of DNA damage and repair pathways by human tumour viruses

Viruses

Volumn 7, Issue 5, 2015, Pages 2542-2591

  Hollingworth, Robert ^a   Grand, Roger J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

DNA damage; DNA repair; EBV; HBV; HCV; HPV; HTLV 1; Human tumour viruses; KSHV; MCPyV

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; EPSTEIN BARR VIRUS ANTIGEN; FANCONI ANEMIA PROTEIN; FLICE INHIBITORY PROTEIN; HEPATITIS B VIRUS X PROTEIN; HISTONE H2AX; INTERFERON REGULATORY FACTOR 1; LATENT MEMBRANE PROTEIN 1; POLO LIKE KINASE 1; PROTEIN TYROSINE PHOSPHATASE; SMALL INTERFERING RNA; TAX PROTEIN;

DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EPSTEIN BARR VIRUS; EXCISION REPAIR; G2 PHASE CELL CYCLE CHECKPOINT; GENOMIC INSTABILITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS; M PHASE CELL CYCLE CHECKPOINT; MERKEL CELL POLYOMAVIRUS; MISMATCH REPAIR; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SINGLE STRANDED DNA BREAK; TUMOR VIRUS; WART VIRUS; CELL TRANSFORMATION; HOST PATHOGEN INTERACTION; PHYSIOLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; HUMAN PAPILLOMAVIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPAIR; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENIC VIRUSES;

EID: 84930934602     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7052542     Document Type: Review

References (262)

1. Weitzman, M.D.; Lilley, C.E.; Chaurushiya, M.S. Genomes in conflict: Maintaining genome integrity during virus infection. Annu. Rev. Microbiol. 2010, 64, 61-81. [CrossRef] [PubMed]
2. Turnell, A.S.; Grand, R.J. DNA viruses and the cellular DNA-damage response. J. Gen. Virol. 2012, 93, 2076-2097. [CrossRef] [PubMed]
3. Meerbrey, K.L.; Hu, G.; Kessler, J.D.; Roarty, K.; Li, M.Z.; Fang, J.E.; Herschkowitz, J.I.; Burrows, A.E.; Ciccia, A.; Sun, T. et al. The pinducer lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2011,108, 3665-3670. [CrossRef] [PubMed]
4. Higgs, M.R.; Chouteau, P.; Lerat, H. 'Liver let die': Oxidative DNA damage and hepatotropic viruses. J. Gen. Virol. 2014, 95, 991-1004. [CrossRef] [PubMed]
5. Marriott, S.J.; Semmes, O.J. Impact of HTLV-I tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005, 24,5986-5995. [CrossRef] [PubMed]
6. Arias, C; Weisburd, B.; Stern-Ginossar, N.; Mercier, A.; Madrid, A.S.; Bellare, P.; Holdorf, M.; Weissman, J.S.; Ganem, D. KSHV 2.0: A comprehensive annotation of the kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog. 2014,10, e1003847. [CrossRef] [PubMed]
7. Nichols, W.W.; Levan, A.; Aula, P.; Norrby, E. Chromosome damage associated with the measles virus in vitro. Hereditas 1965, 54, 101-118. [CrossRef] [PubMed]
8. Fortunato, E.A.; Spector, D.H. Viral induction of site-specific chromosome damage. Rev. Med. Virol. 2003,13, 21-37. [CrossRef] [PubMed]
9. Ashley, A.K.; Shrivastav, M.; Nie, J.; Amerin, C.; Troksa, K.; Glanzer, J.G.; Liu, S.; Opiyo, S.O.; Dimitrova, D.D.; Le, P. et al. DNA-pk phosphorylation of rpa32 ser4/ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe. DNA Repair 2014, 21, 131-139. [CrossRef] [PubMed]
10. Weitzman, M.D.; Lilley, C.E.; Chaurushiya, M.S. Changing the ubiquitin landscape during viral manipulation of the DNA damage response. FEBS Lett. 2011, 585, 2897-2906. [CrossRef] [PubMed]
11. Lilley, C.E.; Chaurushiya, M.S.; Weitzman, M.D. Chromatin at the intersection of viral infection and DNA damage. Biochim. Biophys. Acta 2010,1799, 319-327. [CrossRef] [PubMed]
12. Liu, S.; Bekker-Jensen, S.; Mailand, N.; Lukas, C.; Bartek, J.; Lukas, J. Claspin operates downstream of topbp1 to direct atr signaling towards chk1 activation. Mol. Cell. Biol. 2006, 26, 6056-6064. [CrossRef] [PubMed]
13. Jackson, S.P.; Bartek, J. The DNA-damage response in human biology and disease. Nature 2009, 461, 1071-1078. [CrossRef] [PubMed]
14. Reynolds, J.J.; Stewart, G.S. A single strand that links multiple neuropathologies in human disease. Brain 2013,136, 14-27. [CrossRef] [PubMed]
15. Jeggo, P.A.; Lobrich, M. DNA double-strand breaks: Their cellular and clinical impact? Oncogene 2007, 26, 7717-7719. [CrossRef] [PubMed]
16. Davis, A.J.; Chen, B.P.; Chen, D.J. DNA-pk: A dynamic enzyme in a versatile dsb repair pathway. DNA Repair 2014,17, 21-29. [CrossRef] [PubMed]
17. Cimprich, K.A.; Cortez, D. Atr: An essential regulator of genome integrity. Nat. Rev. Mol. Cell. Biol. 2008, 9, 616-627. [CrossRef] [PubMed]
18. Falck, J.; Coates, J.; Jackson, S.P. Conserved modes of recruitment of atm, atr and DNA-pkcs to sites of DNA damage. Nature 2005, 434, 605-611. [CrossRef] [PubMed]
19. Petrini, J.H.; Stracker, T.H. The cellular response to DNA double-strand breaks: Defining the sensors and mediators. Trends Cell Biol. 2003, 13, 458-462. [CrossRef] [PubMed]
20. Bekker-Jensen, S.; Lukas, C.; Kitagawa, R.; Melander, F.; Kastan, M.B.; Bartek, J.; Lukas, J. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 2006,173, 195-206. [CrossRef] [PubMed]
21. Bakkenist, C.J.; Kastan, M.B. DNA damage activates atm through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421, 499-506. [CrossRef] [PubMed]
22. Sun, Y.; Jiang, X.; Chen, S.; FeRNAndes, N.; Price, B.D. A role for the tip60 histone acetyltransferase in the acetylation and activation of atm. Proc. Natl. Acad. Sci. USA 2005, 102, 13182-13187. [CrossRef] [PubMed]
23. Lou, Z.; Minter-Dykhouse, K.; Franco, S.; Gostissa, M.; Rivera, M.A.; Celeste, A.; Manis, J.P.; van Deursen, J.; Nussenzweig, A.; Paull, T.T. et al. Mdc1 maintains genomic stability by participating in the amplification of atm-dependent DNA damage signals. Mol. Cell 2006, 21, 187-200. [CrossRef] [PubMed]
24. Ciccia, A.; Elledge, S.J. The DNA damage response: Making it safe to play with knives. Mol. Cell 2010, 40, 179-204. [CrossRef] [PubMed]
25. Stewart, G.S.; Panier, S.; Townsend, K.; Al-Hakim, A.K.; Kolas, N.K.; Miller, E.S.; Nakada, S.; Ylanko, J.; Olivarius, S.; Mendez, M. et al. The riddle syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 2009, 136, 420-434. [CrossRef] [PubMed]
26. Bekker-Jensen, S.; Rendtlew Danielsen, J.; Fugger, K.; Gromova, I.; Nerstedt, A.; Lukas, C.; Bartek, J.; Lukas, J.; Mailand, N. Herc2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat. Cell Biol. 2010, 12, 80-86. [CrossRef] [PubMed]
27. Ellison, V.; Stillman, B. Biochemical characterization of DNA damage checkpoint complexes: Clamp loader and clamp complexes with specificity for 5' recessed DNA. PLoS Biol. 2003, 1, e33. [CrossRef] [PubMed]
28. Kumagai, A.; Kim, S.M.; Dunphy, W.G. Claspin and the activated form of atr-atrip collaborate in the activation of chk1. J. Biol. Chem. 2004, 279, 49599-49608. [CrossRef] [PubMed]
29. Kemp, M.G.; Akan, Z.; Yilmaz, S.; Grillo, M.; Smith-Roe, S.L.; Kang, T.H.; Cordeiro-Stone, M.; Kaufmann, W.K.; Abraham, R.T.; Sancar, A. et al. Tipin-replication protein a interaction mediates chk1 phosphorylation by atr in response to genotoxic stress. J. Biol. Chem. 2010, 285, 16562-16571. [CrossRef] [PubMed]
30. Nam, E.A.; Cortez, D. Atr signalling: More than meeting at the fork. Biochem. J. 2011, 436, 527-536. [CrossRef] [PubMed]
31. Lukas, J.; Lukas, C.; Bartek, J. Mammalian cell cycle checkpoints: Signalling pathways and their organization in space and time. DNA Repair 2004, 3, 997-1007. [CrossRef] [PubMed]
32. DeCaprio, J.A. How the rb tumor suppressor structure and function was revealed by the study of adenovirus and sv40. Virology 2009, 384, 274-284. [CrossRef] [PubMed]
33. Jazayeri, A.; Falck, J.; Lukas, C.; Bartek, J.; Smith, G.C.; Lukas, J.; Jackson, S.P. Atm- and cell cycle-dependent regulation of atr in response to DNA double-strand breaks. Nat. Cell Biol. 2006, 8, 37-45. [CrossRef] [PubMed]
34. Sancar, A.; Lindsey-Boltz, L.A.; Unsal-Kacmaz, K.; Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73, 39-85. [CrossRef] [PubMed]
35. Fridman, J.S.; Lowe, S.W. Control of apoptosis by p53. Oncogene 2003, 22, 9030-9040. [CrossRef] [PubMed]
36. Fuentes-Gonzalez, A.M.; Contreras-Paredes, A.; Manzo-Merino, J.; Lizano, M. The modulation of apoptosis by oncogenic viruses. Virol. J. 2013,10, e182. [CrossRef]
37. Cheng, E.H.; Nicholas, J.; Bellows, D.S.; Hayward, G.S.; Guo, H.G.; Reitz, M.S.; Hardwick, J.M. A bcl-2 homolog encoded by kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with bax or bak. Proc. Natl. Acad. Sci. USA 1997, 94, 690-694. [CrossRef] [PubMed]
38. Henderson, S.; Rowe, M.; Gregory, C.; Croom-Carter, D.; Wang, F.; Longnecker, R.; Kieff, E.; Rickinson, A. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected b cells from programmed cell death. Cell 1991, 65, 1107-1115. [CrossRef] [PubMed]
39. Gross-Mesilaty, S.; Reinstein, E.; Bercovich, B.; Tobias, K.E.; Schwartz, A.L.; Kahana, C.; Ciechanover, A. Basal and human papillomavirus e6 oncoprotein-induced degradation of myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. USA 1998, 95, 8058-8063. [CrossRef] [PubMed]
40. Howley, P.M. Warts, cancer and ubiquitylation: Lessons from the papillomaviruses. Trans. Am. Clin. Climatol. Assoc. 2006,117, 113-126, discussion 126-117. [PubMed]
41. Krueger, A.; Fas, S.C.; Giaisi, M.; Bleumink, M.; Merling, A.; Stumpf, C.; Baumann, S.; Holtkotte, D.; Bosch, V.; Krammer, P.H. et al. HTLV-1 tax protects against cd95-mediated apoptosis by induction of the cellular flice-inhibitory protein (c-flip). Blood 2006, 107, 3933-3939. [CrossRef] [PubMed]
42. Hewitt, G.; Jurk, D.; Marques, F.D.; Correia-Melo, C.; Hardy, T.; Gackowska, A.; Anderson, R.; Taschuk, M.; Mann, J.; Passos, J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 3, 708. [CrossRef] [PubMed]
43. Chen, X.; Kamranvar, S.A.; Masucci, M.G. Tumor viruses and replicative immortality-avoiding the telomere hurdle. Semin. Cancer Biol. 2014, 26,43-51. [CrossRef] [PubMed]
44. Zhang, A.; Wang, J.; Zheng, B.; Fang, X.; Angstrom, T.; Liu, C.; Li, X.; Erlandsson, F.; Bjorkholm, M.; Nordenskjord, M. et al. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene 2004,23, 7441-7447. [CrossRef] [PubMed]
45. Miura, N.; Horikawa, I.; Nishimoto, A.; Ohmura, H.; Ito, H.; Hirohashi, S.; Shay, J.W.; Oshimura, M. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet. Cytogenet. 1997, 93, 56-62. [CrossRef] [PubMed]
46. Oh, S.T.; Kyo, S.; Laimins, L.A. Telomerase activation by human papillomavirus type 16 e6 protein: Induction of human telomerase reverse transcriptase expression through myc and gc-rich sp1 binding sites. J. Virol. 2001, 75, 5559-5566. [CrossRef] [PubMed]
47. Zhang, X.; Dong, N.; Zhang, H.; You, J.; Wang, H.; Ye, L. Effects of Hepatitis B virus x protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J. Lab. Clin. Med. 2005,145, 98-104. [CrossRef] [PubMed]
48. Bais, C.; van Geelen, A.; Eroles, P.; Mutlu, A.; Chiozzini, C.; Dias, S.; Silverstein, R.L.; Rafii, S.; Mesri, E.A. Kaposi's sarcoma associated herpesvirus g protein-coupled receptor immortalizes human endothelial cells by activation of the vegf receptor-2/ kdr. Cancer Cell 2003, 3, 131-143. [CrossRef] [PubMed]
49. Yamamoto, A.; Kumakura, S.; Uchida, M.; Barrett, J.C.; Tsutsui, T. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 e6 or e7 gene alone. Int. J. Cancer 2003,106, 301-309. [CrossRef] [PubMed]
50. Srivenugopal, K.S.; Ali-Osman, F. The DNA repair protein, o(6)-methylguanine-DNA methyltransferase is a proteolytic target for the e6 human papillomavirus oncoprotein. Oncogene 2002, 21, 5940-5945. [CrossRef] [PubMed]
51. Iftner, T.; Elbel, M.; Schopp, B.; Hiller, T.; Loizou, J.I.; Caldecott, K.W.; Stubenrauch, F. Interference of papillomavirus e6 protein with single-strand break repair by interaction with xrcc1. EMBO J. 2002, 21, 4741-4748. [CrossRef] [PubMed]
52. Jeang, K.T.; Widen, S.G.; Semmes, O.J.t. Wilson, S.H. HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 1990, 247, 1082-1084. [CrossRef] [PubMed]
53. Demetriou, S.K.; Ona-Vu, K.; Sullivan, E.M.; Dong, T.K.; Hsu, S.W.; Oh, D.H. Defective DNA repair and cell cycle arrest in cells expressing merkel cell polyomavirus T antigen. Int. J. Cancer 2012,131, 1818-1827. [CrossRef] [PubMed]
54. Kao, S.Y.; Marriott, S.J. Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 tax protein. J. Virol. 1999, 73, 4299-4304. [PubMed]
55. Whitehurst, C.B.; Vaziri, C.; Shackelford, J.; Pagano, J.S. Epstein-barr virus bplf1 deubiquitinates pcna and attenuates polymerase eta recruitment to DNA damage sites. J. Virol. 2012, 86, 8097-8106. [CrossRef] [PubMed]
56. Lee, T.H.; Elledge, S.J.; Butel, J.S. Hepatitis B virus x protein interacts with a probable cellular DNA repair protein. J. Virol. 1995, 69, 1107-1114. [PubMed]
57. Sitterlin, D.; Lee, T.H.; Prigent, S.; Tiollais, P.; Butel, J.S.; Transy, C. Interaction of the UV-damaged DNA-binding protein with Hepatitis B virus x protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient x-insertion mutants. J. Virol. 1997, 71, 6194-6199. [PubMed]
58. Qadri, I.; Conaway, J.W.; Conaway, R.C.; Schaack, J.; Siddiqui, A. Hepatitis B virus transactivator protein, hbx, associates with the components of tfiih and stimulates the DNA helicase activity of tfiih. Proc. Natl. Acad. Sci. USA 1996, 93, 10578-10583. [CrossRef] [PubMed]
59. Qadri, I.; Fatima, K.; Abde, L.H.H. Hepatitis B virus x protein impedes the DNA repair via its association with transcription factor, tfiih. BMC Microbiol. 2011,11, e48. [CrossRef]
60. Wang, Y.; Li, H.; Tang, Q.; Maul, G.G.; Yuan, Y. Kaposi's sarcoma-associated herpesvirus ori-lyt-dependent DNA replication: Involvement of host cellular factors. J. Virol. 2008, 82, 2867-2882. [CrossRef] [PubMed]
61. Morimoto, H.; Tsukada, J.; Kominato, Y.; Tanaka, Y. Reduced expression of human mismatch repair genes in adult T-cell leukemia. Am. J. Hematol. 2005, 78, 100-107. [CrossRef] [PubMed]
62. Daikoku, T.; Kudoh, A.; Sugaya, Y.; Iwahori, S.; Shirata, N.; Isomura, H.; Tsurumi, T. Postreplicative mismatch repair factors are recruited to epstein-barr virus replication compartments. J. Biol. Chem. 2006, 281, 11422-11430. [CrossRef] [PubMed]
63. Park, J.W.; Nickel, K.P.; Torres, A.D.; Lee, D.; Lambert, P.F.; Kimple, R.J. Human papillomavirus type 16 e7 oncoprotein causes a delay in repair of DNA damage. Radiother Oncol. 2014, 113, 337-344. [CrossRef] [PubMed]
64. Kudoh, A.; Iwahori, S.; Sato, Y.; Nakayama, S.; Isomura, H.; Murata, T.; Tsurumi, T. Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in epstein-barr virus replication compartments. J. Virol. 2009, 83, 6641-6651. [CrossRef] [PubMed]
65. Gillespie, K.A.; Mehta, K.P.; Laimins, L.A.; Moody, C.A. Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J. Virol. 2012, 86, 9520-9526. [CrossRef] [PubMed]
66. Belgnaoui, S.M.; Fryrear, K.A.; Nyalwidhe, J.O.; Guo, X.; Semmes, O.J. The viral oncoprotein tax sequesters DNA damage response factors by tethering mdc1 to chromatin. J. Biol. Chem. 2010, 285, 32897-32905. [CrossRef] [PubMed]
67. Xiao, Y.; Chen, J.; Liao, Q.; Wu, Y.; Peng, C.; Chen, X. Lytic infection of kaposi's sarcoma-associated herpesvirus induces DNA double-strand breaks and impairs non-homologous end joining. J. Gen. Virol. 2013, 94, 1870-1875. [CrossRef] [PubMed]
68. Gottlieb, T.M.; Jackson, S.P. The DNA-dependent protein kinase: Requirement for DNA ends and association with ku antigen. Cell 1993, 72, 131-142. [CrossRef] [PubMed]
69. Nick McElhinny, S.A.; Snowden, C.M.; McCarville, J.; Ramsden, D.A. Ku recruits the xrcc4-ligase iv complex to DNA ends. Mol. Cell. Biol. 2000, 20, 2996-3003. [CrossRef] [PubMed]
70. Hartlerode, A.J.; Scully, R. Mechanisms of double-strand break repair in somatic mammalian cells. Biochem. J. 2009, 423, 157-168. [CrossRef] [PubMed]
71. Grawunder, U.; Wilm, M.; Wu, X.; Kulesza, P.; Wilson, T.E.; Mann, M.; Lieber, M.R. Activity of DNA ligase iv stimulated by complex formation with xrcc4 protein in mammalian cells. Nature 1997, 388, 492-495. [CrossRef] [PubMed]
72. Ahnesorg, P.; Smith, P.; Jackson, S.P. Xlf interacts with the xrcc4-DNA ligase iv complex to promote DNA nonhomologous end-joining. Cell 2006,124, 301-313. [CrossRef] [PubMed]
73. Sartori, A.A.; Lukas, C.; Coates, J.; Mistrik, M.; Fu, S.; Bartek, J.; Baer, R.; Lukas, J.; Jackson, S.P. Human CtIP promotes DNA end resection. Nature 2007,450, 509-514. [CrossRef] [PubMed]
74. Symington, L.S.; Gautier, J. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 2011, 45, 247-271. [CrossRef] [PubMed]
75. Nimonkar, A.V.; Sica, R.A.; Kowalczykowski, S.C. Rad52 promotes second-end DNA capture in double-stranded break repair to form complement-stabilized joint molecules. Proc. Natl. Acad. Sci. USA 2009, 106, 3077-3082. [CrossRef] [PubMed]
76. Nimonkar, A.V.; Genschel, J.; Kinoshita, E.; Polaczek, P.; Campbell, J.L.; Wyman, C.; Modrich, P.; Kowalczykowski, S.C. Blm-dna2-rpa-mrn and exo1-blm-rpa-mrn constitute two DNA end resection machineries for human DNA break repair. Genes Dev. 2011, 25, 350-362. [CrossRef] [PubMed]
77. McIlwraith, M.J.; West, S.C. DNA repair synthesis facilitates rad52-mediated second-end capture during dsb repair. Mol. Cell 2008,29, 510-516. [CrossRef] [PubMed]
78. Nimonkar, A.V.; Kowalczykowski, S.C. Second-end DNA capture in double-strand break repair: How to catch a DNA by its tail. Cell Cycle 2009, 8, 1816-1817. [CrossRef] [PubMed]
79. Caldecott, K.W. DNA single-strand break repair. Exp. Cell Res. 2014, 329, 2-8. [CrossRef] [PubMed]
80. D'Amours, D.; Desnoyers, S.; D'Silva, I.; Poirier, G.G. Poly(adp-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 1999, 342, 249-268. [CrossRef] [PubMed]
81. Caldecott, K.W. Single-strand break repair and genetic disease. Nat. Rev. Genet. 2008, 9, 619-631. [PubMed]
82. Caldecott, K.W.; Aoufouchi, S.; Johnson, P.; Shall, S. Xrcc1 polypeptide interacts with DNA polymerase beta and possibly poly(adp-ribose) polymerase, and DNA ligase iii is a novel molecular 'nick-sensor' in vitro. Nucl. Acids Res. 1996, 24, 4387-4394. [CrossRef] [PubMed]
83. Whitehouse, C.J.; Taylor, R.M.; Thistlethwaite, A.; Zhang, H.; Karimi-Busheri, F.; Lasko, D.D.; Weinfeld, M.; Caldecott, K.W. Xrcc1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001, 104, 107-117. [CrossRef] [PubMed]
84. Caldecott, K.W. Mammalian single-strand break repair: Mechanisms and links with chromatin. DNA Repair 2007, 6, 443-453. [CrossRef] [PubMed]
85. Sedgwick, B. Repairing DNA-methylation damage. Nat Rev Mol. Cell. Biol. 2004, 5, 148-157. [CrossRef] [PubMed]
86. Sedgwick, B.; Bates, P.A.; Paik, J.; Jacobs, S.C.; Lindahl, T. Repair of alkylated DNA: Recent advances. DNA Repair 2007, 6, 429-442. [CrossRef] [PubMed]
87. Parsons, J.L.; Dianov, G.L. Co-ordination of base excision repair and genome stability. DNA Repair 2013, 12, 326-333. [CrossRef] [PubMed]
88. Dutta, A.; Yang, C.; Sengupta, S.; Mitra, S.; Hegde, M.L. New paradigms in the repair of oxidative damage in human genome: Mechanisms ensuring repair of mutagenic base lesions during replication and involvement of accessory proteins. Cell. Mol. Life Sci. 2015, 72, 1679-1698. [CrossRef] [PubMed]
89. Wallace, S.S. Base excision repair: A critical player in many games. DNA Repair 2014, 19, 14-26. [CrossRef] [PubMed]
90. Alekseev, S.; Coin, F. Orchestral maneuvers at the damaged sites in nucleotide excision repair. Cell. Mol. Life Sci. 2015, 72, 2177-2186. [CrossRef] [PubMed]
91. Vermeulen, W.; Fousteri, M. Mammalian transcription-coupled excision repair. Cold Spring Harb. Perspect. Biol. 2013, 5. [CrossRef]
92. de Laat, W.L.; Jaspers, N.G.; Hoeijmakers, J.H. Molecular mechanism of nucleotide excision repair. Genes Dev. 1999, 13, 768-785. [CrossRef] [PubMed]
93. Marteijn, J.A.; Lans, H.; Vermeulen, W.; Hoeijmakers, J.H. Understanding nucleotide excision repair and its roles in cancer and ageing. Nat. Rev. Mol. Cell. Biol. 2014, 15, 465-481. [CrossRef] [PubMed]
94. Li, G.M. New insights and challenges in mismatch repair: Getting over the chromatin hurdle. DNA Repair 2014, 19, 48-54. [CrossRef] [PubMed]
95. Kunkel, T.A.; Erie, D.A. DNA mismatch repair. Annu. Rev. Biochem. 2005, 74, 681-710. [CrossRef] [PubMed]
96. Jiricny, J. The multifaceted mismatch-repair system. Nat Rev Mol. Cell. Biol. 2006, 7, 335-346. [CrossRef] [PubMed]
97. Genschel, J.; Modrich, P. Mechanism of 5'-directed excision in human mismatch repair. Mol. Cell 2003,12, 1077-1086. [CrossRef] [PubMed]
98. Williams, J.S.; Kunkel, T.A. Ribonucleotides in DNA: Origins, repair and consequences. DNA Repair 2014, 19, 27-37. [CrossRef] [PubMed]
99. Walden, H.; Deans, A.J. The fanconi anemia DNA repair pathway: Structural and functional insights into a complex disorder. Annu. Rev. Biophys. 2014, 43, 257-278. [CrossRef] [PubMed]
100. Kim, H.; D'Andrea, A.D. Regulation of DNA cross-link repair by the fanconi anemia/brca pathway. Genes Dev. 2012, 26, 1393-1408. [CrossRef] [PubMed]
101. Branzei, D.; Foiani, M. Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell. Biol. 2008, 9, 297-308. [CrossRef] [PubMed]
102. You, Z.; Bailis, J.M. DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints. Trends Cell Biol. 2010, 20, 402-409. [CrossRef] [PubMed]
103. Germani, A.; Prabel, A.; Mourah, S.; Podgorniak, M.P.; Di Carlo, A.; Ehrlich, R.; Gisselbrecht, S.; Varin-Blank, N.; Calvo, F.; Bruzzoni-Giovanelli, H. Siah-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene 2003, 22, 8845-8851. [CrossRef] [PubMed]
104. Schroering, A.G.; Edelbrock, M.A.; Richards, T.J.; Williams, K.J. The cell cycle and DNA mismatch repair. Exp. Cell Res. 2007, 313, 292-304. [CrossRef] [PubMed]
105. Chaudhry, M.A. Base excision repair of ionizing radiation-induced DNA damage in g1 and g2 cell cycle phases. Cancer Cell Int. 2007, 7, e15. [CrossRef]
106. Ghosal, G.; Chen, J. DNA damage tolerance: A double-edged sword guarding the genome. Transl. Cancer Res. 2013, 2, 107-129. [PubMed]
107. Walboomers, J.M.; Jacobs, M.V.; Manos, M.M.; Bosch, F.X.; Kummer, J.A.; Shah, K.V.; Snijders, P.J.; Peto, J.; Meijer, C.J.; Munoz, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189, 12-19. [CrossRef] [PubMed]
108. Clifford, G.M.; Rana, R.K.; Franceschi, S.; Smith, J.S.; Gough, G.; Pimenta, J.M. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1157-1164. [CrossRef] [PubMed]
109. Cooper, K.; Herrington, C.S.; Stickland, J.E.; Evans, M.F.; McGee, J.O. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J. Clin. Pathol. 1991, 44, 990-996. [CrossRef] [PubMed]
110. Zheng, Z.M.; Baker, C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 2006, 11, 2286-2302. [CrossRef] [PubMed]
111. Crook, T.; Tidy, J.A.; Vousden, K.H. Degradation of p53 can be targeted by HPV e6 sequences distinct from those required for p53 binding and trans-activation. Cell 1991, 67, 547-556. [CrossRef] [PubMed]
112. Jones, D.L.; Munger, K. Interactions of the human papillomavirus e7 protein with cell cycle regulators. Semin. Cancer Biol. 1996, 7, 327-337. [CrossRef] [PubMed]
113. Moody, C.A.; Laimins, L.A. Human papillomaviruses activate the atm DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 2009, 5, e1000605. [CrossRef] [PubMed]
114. Fradet-Turcotte, A.; Bergeron-Labrecque, F.; Moody, C.A.; Lehoux, M.; Laimins, L.A.; Archambault, J. Nuclear accumulation of the papillomavirus e1 helicase blocks s-phase progression and triggers an atm-dependent DNA damage response. J. Virol. 2011, 85, 8996-9012. [CrossRef] [PubMed]
115. Sakakibara, N.; Mitra, R.; McBride, A.A. The papillomavirus e1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 2011, 85, 8981-8995. [CrossRef] [PubMed]
116. Reinson, T.; Toots, M.; Kadaja, M.; Pipitch, R.; Allik, M.; Ustav, E.; Ustav, M. Engagement of the atr-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification. J. Virol. 2013, 87, 951-964. [CrossRef] [PubMed]
117. Kadaja, M.; Isok-Paas, H.; Laos, T.; Ustav, E.; Ustav, M. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog. 2009, 5, e1000397. [CrossRef] [PubMed]
118. Kadaja, M.; Sumerina, A.; Verst, T.; Ojarand, M.; Ustav, E.; Ustav, M. Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J. 2007, 26, 2180-2191. [CrossRef] [PubMed]
119. Sun, R.; Lin, S.F.; Gradoville, L.; Yuan, Y.; Zhu, F.; Miller, G. A viral gene that activates lytic cycle expression of kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 1998, 95, 10866-10871. [CrossRef] [PubMed]
120. Spardy, N.; Duensing, A.; Charles, D.; Haines, N.; Nakahara, T.; Lambert, P.F.; Duensing, S. The human papillomavirus type 16 e7 oncoprotein activates the fanconi anemia (fa) pathway and causes accelerated chromosomal instability in fa cells. J. Virol. 2007, 81, 13265-13270. [CrossRef] [PubMed]
121. Park, J.W.; Pitot, H.C.; Strati, K.; Spardy, N.; Duensing, S.; Grompe, M.; Lambert, P.F. Deficiencies in the fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. Cancer Res. 2010, 70, 9959-9968. [CrossRef] [PubMed]
122. Donaldson, M.M.; Mackintosh, L.J.; Bodily, J.M.; DoRNAn, E.S.; Laimins, L.A.; Morgan, I.M. An interaction between human papillomavirus 16 e2 and topbp1 is required for optimum viral DNA replication and episomal genome establishment. J. Virol. 2012, 86, 12806-12815. [CrossRef] [PubMed]
123. Chen, B.; Simpson, D.A.; Zhou, Y.; Mitra, A.; Mitchell, D.L.; Cordeiro-Stone, M.; Kaufmann, W.K. Human papilloma virus type16 e6 deregulates chk1 and sensitizes human fibroblasts to environmental carcinogens independently of its effect on p53. Cell Cycle 2009, 8, 1775-1787. [CrossRef] [PubMed]
124. Wallace, N.A.; Robinson, K.; Howie, H.L.; Galloway, D.A. HPV 5 and 8 e6 abrogate atr activity resulting in increased persistence of uvb induced DNA damage. PLoS Pathog. 2012, 8, e1002807. [CrossRef] [PubMed]
125. Winder, D.M.; Pett, M.R.; Foster, N.; Shivji, M.K.; Herdman, M.T.; Stanley, M.A.; Venkitaraman, A.R.; Coleman, N. An increase in DNA double-strand breaks, induced by ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J. Pathol. 2007, 213, 27-34. [CrossRef] [PubMed]
126. Williams, V.M.; Filippova, M.; Filippov, V.; Payne, K.J.; Duerksen-Hughes, P. Human papillomavirus type 16 e6* induces oxidative stress and DNA damage. J. Virol. 2014, 88, 6751-6761. [CrossRef] [PubMed]
127. Feng, H.; Shuda, M.; Chang, Y.; Moore, P.S. Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 2008, 319, 1096-1100. [CrossRef] [PubMed]
128. Sastre-Garau, X.; Peter, M.; Avril, M.F.; Laude, H.; Couturier, J.; Rozenberg, F.; Almeida, A.; Boitier, F.; Carlotti, A.; Couturaud, B. et al. Merkel cell carcinoma of the skin: Pathological and molecular evidence for a causative role of mcV in oncogenesis. J. Pathol. 2009, 218, 48-56. [CrossRef] [PubMed]
129. Shuda, M.; Kwun, H.J.; Feng, H.; Chang, Y.; Moore, P.S. Human merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4e-bp1 translation regulator. J. Clin. Invest. 2011, 121, 3623-3634. [CrossRef] [PubMed]
130. Griffiths, D.A.; Abdul-Sada, H.; Knight, L.M.; Jackson, B.R.; Richards, K.; Prescott, E.L.; Peach, A.H.; Blair, G.E.; Macdonald, A.; Whitehouse, A. Merkel cell polyomavirus small T antigen targets the nemo adaptor protein to disrupt inflammatory signaling. J. Virol. 2013, 87, 13853-13867. [CrossRef] [PubMed]
131. Shuda, M.; Feng, H.; Kwun, H.J.; Rosen, S.T.; Gjoerup, O.; Moore, P.S.; Chang, Y. T antigen mutations are a human tumor-specific signature for merkel cell polyomavirus. Proc. Natl. Acad. Sci. USA 2008,105, 16272-16277. [CrossRef] [PubMed]
132. Kwun, H.J.; Guastafierro, A.; Shuda, M.; Meinke, G.; Bohm, A.; Moore, P.S.; Chang, Y. The minimum replication origin of merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication. J. Virol. 2009, 83, 12118-12128. [CrossRef] [PubMed]
133. Li, J.; Wang, X.; Diaz, J.; Tsang, S.H.; Buck, C.B.; You, J. Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation. J. Virol. 2013, 87, 9173-9188. [CrossRef] [PubMed]
134. Tsang, S.H.; Wang, X.; Li, J.; Buck, C.B.; You, J. Host DNA damage response factors localize to merkel cell polyomavirus DNA replication sites to support efficient viral DNA replication. J. Virol. 2014, 88, 3285-3297. [CrossRef] [PubMed]
135. Martin, D.F.; Kuppermann, B.D.; Wolitz, R.A.; Palestine, A.G.; Li, H.; Robinson, C.A. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche ganciclovir study group. N. Engl. J. Med. 1999, 340, 1063-1070. [CrossRef] [PubMed]
136. Li, J.; Diaz, J.; Wang, X.; Tsang, S.H.; You, J. Phosphorylation of merkel cell polyomavirus large tumor antigen at serine 816 by atm kinase induces apoptosis in host cells. J. Biol. Chem. 2015, 290, 1874-1884. [CrossRef] [PubMed]
137. Chang, C.M.; Yu, K.J.; Mbulaiteye, S.M.; Hildesheim, A.; Bhatia, K. The extent of genetic diversity of epstein-barr virus and its geographic and disease patterns: A need for reappraisal. Virus Res. 2009,143, 209-221. [CrossRef] [PubMed]
138. Grundhoff, A.; Ganem, D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in kaposi sarcoma pathogenesis. J. Clin. Invest. 2004, 113, 124-136. [CrossRef] [PubMed]
139. Young, L.S.; Rickinson, A.B. Epstein-barr virus: 40 years on. Nat. Rev. Cancer 2004,4,757-768. [CrossRef] [PubMed]
140. Kamranvar, S.A.; Gruhne, B.; Szeles, A.; Masucci, M.G. Epstein-barr virus promotes genomic instability in burkitt's lymphoma. Oncogene 2007, 26, 5115-5123. [CrossRef] [PubMed]
141. Gruhne, B.; Kamranvar, S.A.; Masucci, M.G.; Sompallae, R. Ebv and genomic instability-a new look at the role of the virus in the pathogenesis of burkitt's lymphoma. Semin. Cancer Biol. 2009, 19, 394-400. [CrossRef] [PubMed]
142. Kamranvar, S.A.; Masucci, M.G. The epstein-barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress. Leukemia 2011, 25, 1017-1025. [CrossRef] [PubMed]
143. Liu, M.T.; Chen, Y.R.; Chen, S.C.; Hu, C.Y.; Lin, C.S.; Chang, Y.T.; Wang, W.B.; Chen, J.Y. Epstein-barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene 2004, 23, 2531-2539. [CrossRef] [PubMed]
144. Chen, Y.R.; Liu, M.T.; Chang, Y.T.; Wu, C.C.; Hu, C.Y.; Chen, J.Y. Epstein-barr virus latent membrane protein 1 represses DNA repair through the pi3k/akt/foxo3a pathway in human epithelial cells. J. Virol. 2008, 82, 8124-8137. [CrossRef] [PubMed]
145. Chiu, S.H.; Wu, C.C.; Fang, C.Y.; Yu, S.L.; Hsu, H.Y.; Chow, Y.H.; Chen, J.Y. Epstein-barr virus balf3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma. Oncotarget 2014, 5, 8583-8601. [PubMed]
146. Chang, Y.H.; Lee, C.P.; Su, M.T.; Wang, J.T.; Chen, J.Y.; Lin, S.F.; Tsai, C.H.; Hsieh, M.J.; Takada, K.; Chen, M.R. Epstein-barr virus bglf4 kinase retards cellular s-phase progression and induces chromosomal abnormality. PLoS ONE 2012, 7, e39217. [CrossRef] [PubMed]
147. Wu, C.C.; Liu, M.T.; Chang, Y.T.; Fang, C.Y.; Chou, S.P.; Liao, H.W.; Kuo, K.L.; Hsu, S.L.; Chen, Y.R.; Wang, P.W. et al. Epstein-barr virus dnase (bglf5) induces genomic instability in human epithelial cells. Nucl. Acids Res. 2010, 38, 1932-1949. [CrossRef] [PubMed]
148. Kudoh, A.; Fujita, M.; Zhang, L.; Shirata, N.; Daikoku, T.; Sugaya, Y.; Isomura, H.; Nishiyama, Y.; Tsurumi, T. Epstein-barr virus lytic replication elicits atm checkpoint signal transduction while providing an s-phase-like cellular environment. J. Biol. Chem. 2005, 280, 8156-8163. [CrossRef] [PubMed]
149. Bailey, S.G.; Verrall, E.; Schelcher, C.; Rhie, A.; Doherty, A.J.; Sinclair, A.J. Functional interaction between epstein-barr virus replication protein zta and host DNA damage response protein 53bp1. J. Virol. 2009, 83, 11116-11122. [CrossRef] [PubMed]
150. Li, R.; Zhu, J.; Xie, Z.; Liao, G.; Liu, J.; Chen, M.R.; Hu, S.; Woodard, C.; Lin, J.; Tave, S.D et al. Conserved herpesvirus kinases target the DNA damage response pathway and tip60 histone acetyltransferase to promote virus replication. Cell Host Microbe 2011, 10, 390-400. [CrossRef] [PubMed]
151. Hagemeier, S.R.; Barlow, E.A.; Meng, Q.; Kenney, S.C. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. J. Virol. 2012, 86, 13360-13370. [CrossRef] [PubMed]
152. Hau, P.M.; Deng, W.; Jia, L.; Yang, J.; Tsurumi, T.; Chiang, A.K.; Huen, M.S.; Tsao, S.W. Role of atm in the formation of the replication compartment during lytic replication of epstein-barr virus in nasopharyngeal epithelial cells. J. Virol. 2015, 89, 652-668. [CrossRef] [PubMed]
153. Nikitin, P.A.; Yan, C.M.; Forte, E.; Bocedi, A.; Tourigny, J.P.; White, R.E.; Allday, M.J.; Patel, A.; Dave, S.S.; Kim, W. et al. An atm/chk2-mediated DNA damage-responsive signaling pathway suppresses epstein-barr virus transformation of primary human b cells. Cell Host Microbe 2010, 8, 510-522. [CrossRef] [PubMed]
154. Koganti, S.; Hui-Yuen, J.; McAllister, S.; Gardner, B.; Grasser, F.; Palendira, U.; Tangye, S.G.; Freeman, A.F.; Bhaduri-McIntosh, S. Stat3 interrupts atr-chk1 signaling to allow oncovirus-mediated cell proliferation. Proc. Natl. Acad. Sci. USA 2014, 111, 4946-4951. [CrossRef] [PubMed]
155. Choudhuri, T.; Verma, S.C.; Lan, K.; Murakami, M.; Robertson, E.S. The atm/atr signaling effector chk2 is targeted by epstein-barr virus nuclear antigen 3c to release the g2/m cell cycle block. J. Virol. 2007, 81, 6718-6730. [CrossRef] [PubMed]
156. Jha, H.C.; M. Saha, A. Banerjee; Lu, J.; Robertson, E.S. Epstein-barr virus essential antigen ebna3c attenuates h2ax expression. J. Virol. 2014, 88, 3776-3788. [CrossRef] [PubMed]
157. Deng, W.; Pang, P.S.; Tsang, C.M.; Hau, P.M.; Yip, Y.L.; Cheung, A.L.; Tsao, S.W. Epstein-barr virus-encoded latent membrane protein 1 impairs g2 checkpoint in human nasopharyngeal epithelial cells through defective chk1 activation. PLoS ONE 2012, 7, e39095. [CrossRef] [PubMed]
158. Dheekollu, J.; Deng, Z.; Wiedmer, A.; Weitzman, M.D.; Lieberman, P.M. A role for mre11, nbs1, and recombination junctions in replication and stable maintenance of ebv episomes. PLoS ONE 2007, 2, e1257. [CrossRef] [PubMed]
159. Chang, Y.; Cesarman, E.; Pessin, M.S.; Lee, F.; Culpepper, J.; Knowles, D.M.; Moore, P.S. Identification of herpesvirus-like DNA sequences in aids-associated kaposi's sarcoma. Science 1994, 266, 1865-1869. [CrossRef] [PubMed]
160. Cesarman, E.; Chang, Y.; Moore, P.S.; Said, J.W.; Knowles, D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in aids-related body-cavity-based lymphomas. N. Engl. J. Med. 1995, 332, 1186-1191. [CrossRef] [PubMed]
161. Soulier, J.; Grollet, L.; Oksenhendler, E.; Cacoub, P.; Cazals-Hatem, D.; Babinet, P.; d'Agay, M.F.; Clauvel, J.P.; Raphael, M.; Degos, L. et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric castleman's disease. Blood 1995, 86,1276-1280. [PubMed]
162. Dittmer, D.P. Transcription profile of kaposi's sarcoma-associated herpesvirus in primary kaposi's sarcoma lesions as determined by real-time pcr arrays. Cancer Res. 2003, 63, 2010-2015. [PubMed]
163. Guito, J.; Lukac, D.M. KSHV reactivation and novel implications of protein isomerization on lytic switch control. Viruses 2015, 7, 72-109. [CrossRef] [PubMed]
164. Uppal, T.; Banerjee, S.; Sun, Z.; Verma, S.C.; Robertson, E.S. KSHV lana-the master regulator of KSHV latency. Viruses 2014, 6, 4961-4998. [CrossRef] [PubMed]
165. Mesri, E.A.; Cesarman, E.; Boshoff, C. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 2010,10,707-719. [CrossRef] [PubMed]
166. Jha, H.C.; Upadhyay, S.K.; Lu, J.; Cai, Q.; Saha, A.; Robertson, E.S. H2ax phosphorylation is important for lana-mediated kaposi's sarcoma-associated herpesvirus episome persistence. J. Virol. 2013, 87, 5255-5269. [CrossRef] [PubMed]
167. Singh, V.V.; Dutta, D.; Ansari, M.A.; Dutta, S.; Chandran, B. Kaposi's sarcoma-associated herpesvirus induces the atm and h2ax DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment. J. Virol. 2014, 88, 2821-2834. [CrossRef] [PubMed]
168. Koopal, S.; Furuhjelm, J.H.; Jarviluoma, A.; Jaamaa, S.; Pyakurel, P.; Pussinen, C.; Wirzenius, M.; Biberfeld, P.; Alitalo, K.; Laiho, M.; et al. Viral oncogene-induced DNA damage response is activated in kaposi sarcoma tumorigenesis. PLoS Pathog. 2007, 3, 1348-1360. [CrossRef] [PubMed]
169. Verschuren, E.W.; Klefstrom, J.; Evan, G.I.; Jones, N. The oncogenic potential of kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2002, 2, 229-241. [CrossRef] [PubMed]
170. Pan, H.; Zhou, F.; Gao, S.J. Kaposi's sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res. 2004, 64, 4064-4068. [CrossRef] [PubMed]
171. Kumar, A.; Sahu, S.K.; Mohanty, S.; Chakrabarti, S.; Maji, S.; Reddy, R.R.; Jha, A.K.; Goswami, C.; Kundu, C.N.; Rajasubramaniam, S. et al. Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the g2/m cell cycle blocks by modulating atm/atr mediated checkpoint pathway. PLoS ONE 2014, 9, e100228. [CrossRef] [PubMed]
172. Gwack, Y.; Nakamura, H.; Lee, S.H.; Souvlis, J.; Yustein, J.T.; Gygi, S.; Kung, H.J.; Jung, J.U. Poly(adp-ribose) polymerase 1 and ste20-like kinase hkfc act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol. Cell. Biol. 2003, 23, 8282-8294. [CrossRef] [PubMed]
173. Jackson, B.R.; Noerenberg, M.; Whitehouse, A. A novel mechanism inducing genome instability in kaposi's sarcoma-associated herpesvirus infected cells. PLoS Pathog. 2014, 10, e1004098. [CrossRef] [PubMed]
174. Shin, Y.C.; Nakamura, H.; Liang, X.; Feng, P.; Chang, H.; Kowalik, T.F.; Jung, J.U. Inhibition of the atm/p53 signal transduction pathway by kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J. Virol. 2006, 80, 2257-2266. [CrossRef] [PubMed]
175. Krishnan, H.H.; Naranatt, P.P.; Smith, M.S.; Zeng, L.; Bloomer, C.; Chandran, B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 2004, 78, 3601-3620. [CrossRef] [PubMed]
176. Ma, S.D.; Hegde, S.; Young, K.H.; Sullivan, R.; Rajesh, D.; Zhou, Y.; Jankowska-Gan, E.; Burlingham, W.J.; Sun, X.; Gulley, M.L. et al. A new model of epstein-barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J. Virol. 2011, 85, 165-177. [CrossRef] [PubMed]
177. Franchini, G.; Nicot, C.; Johnson, J.M. Seizing of t cells by human T-cell leukemia/lymphoma virus type 1. Adv. Cancer Res. 2003, 89, 69-132. [PubMed]
178. Matsuoka, M.; Jeang, K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7, 270-280. [CrossRef] [PubMed]
179. Korber, B.; Okayama, A.; Donnelly, R.; Tachibana, N.; Essex, M. Polymerase chain reaction analysis of defective human T-cell leukemia virus type i proviral genomes in leukemic cells of patients with adult T-cell leukemia. J. Virol. 1991, 65, 5471-5476. [PubMed]
180. Grassmann, R.; Dengler, C.; Muller-Fleckenstein, I.; Fleckenstein, B.; McGuire, K.; Dokhelar, M.C.; Sodroski, J.G.; Haseltine, W.A. Transformation to continuous growth ofprimary human T lymphocytes by human T-cell leukemia virus type i x-region genes transduced by a herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA 1989, 86, 3351-3355. [CrossRef] [PubMed]
181. Grassmann, R.; Berchtold, S.; Radant, I.; Alt, M.; Fleckenstein, B.; Sodroski, J.G.; Haseltine, W.A.; Ramstedt, U. Role of human T-cell leukemia virus type 1 x region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 1992, 66, 4570-4575. [PubMed]
182. Hara, T.; Matsumura-Arioka, Y.; Ohtani, K.; Nakamura, M. Role of human T-cell leukemia virus type i tax in expression of the human telomerase reverse transcriptase (htert) gene in human T-cells. Cancer Sci 2008, 99, 1155-1163. [CrossRef] [PubMed]
183. Pise-Masison, C.A.; Mahieux, R.; Jiang, H.; Ashcroft, M.; Radonovich, M.; Duvall, J.; Guillerm, C.; Brady, J.N. Inactivation of p53 by human T-cell lymphotropic virus type 1 tax requires activation of the nf-kappab pathway and is dependent on p53 phosphorylation. Mol. Cell. Biol. 2000, 20, 3377-3386. [CrossRef] [PubMed]
184. Kehn, K.; Fuente Cde, L.; Strouss, K.; Berro, R.; Jiang, H.; Brady, J.; Mahieux, R.; Pumfery, A.; Bottazzi, M.E.; Kashanchi, F. The HTLV-I tax oncoprotein targets the retinoblastoma protein for proteasomal degradation. Oncogene 2005, 24, 525-540. [CrossRef] [PubMed]
185. Semmes, O.J.; Jeang, K.T. Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles. J. Virol. 1996, 70, 6347-6357. [PubMed]
186. Bex, F.; McDowall, A.; Burny, A.; Gaynor, R. The human T-cell leukemia virus type 1 transactivator protein tax colocalizes in unique nuclear structures with nf-kappab proteins. J. Virol. 1997, 71, 3484-3497. [PubMed]
187. Majone, F.; Semmes, O.J.; Jeang, K.T. Induction of micronuclei by HTLV-I tax: A cellular assay for function. Virology 1993,193, 456-459. [CrossRef] [PubMed]
188. Philpott, S.M.; Buehring, G.C. Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: Role of tax gene. J. Natl. Cancer Inst. 1999, 91, 933-942. [CrossRef] [PubMed]
189. Baydoun, H.H.; Bai, X.T.; Shelton, S.; Nicot, C. HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to nhej. PLoS ONE 2012, 7, e42226. [CrossRef] [PubMed]
190. Mihaylova, V.T.; Green, A.M.; Khurgel, M.; Semmes, O.J.; Kupfer, G.M. Human T-cell leukemia virus i tax protein sensitizes p53-mutant cells to DNA damage. Cancer Res. 2008,68,4843-4852. [CrossRef] [PubMed]
191. Kinjo, T.; Ham-Terhune, J.; Peloponese, J.M., Jr.; Jeang, K.T. Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker. J. Virol. 2010, 84, 5431-5437. [CrossRef] [PubMed]
192. Chaib-Mezrag, H.; Lemacon, D.; Fontaine, H.; Bellon, M.; Bai, X.T.; Drac, M.; Coquelle, A.; Nicot, C. Tax impairs DNA replication forks and increases DNA breaks in speciic oncogenic genome regions. Mol. Cancer 2014, 13, e205. [CrossRef]
193. Miyake, H.; Suzuki, T.; Hirai, H.; Yoshida, M. Trans-activator tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. Virology 1999, 253, 155-161. [CrossRef] [PubMed]
194. Cannon, J.S.; Hamzeh, F.; Moore, S.; Nicholas, J.; Ambinder, R.F. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J. Virol. 1999, 73, 4786-4793. [PubMed]
195. Schavinsky-Khrapunsky, Y.; Priel, E.; Aboud, M. Dose-dependent dual effect of HTLV-1 tax oncoprotein on p53-dependent nucleotide excision repair in human T-cells. Int. J. Cancer 2008, 122, 305-316. [CrossRef] [PubMed]
196. Chandhasin, C.; Ducu, R.I.; Berkovich, E.; Kastan, M.B.; Marriott, S.J. Human T-cell leukemia virus type 1 tax attenuates the atm-mediated cellular DNA damage response. J. Virol. 2008, 82, 6952-6961. [CrossRef] [PubMed]
197. Dayaram, T.; Lemoine, F.J.; Donehower, L.A.; Marriott, S.J. Activation of wip1 phosphatase by HTLV-1 tax mitigates the cellular response to DNA damage. PLoS ONE 2013, 8, e55989. [CrossRef] [PubMed]
198. Majone, F.; Luisetto, R.; Zamboni, D.; Iwanaga, Y.; Jeang, K.T. Ku protein as a potential human T-cell leukemia virus type 1 (HTLV-1) tax target in clastogenic chromosomal instability of mammalian cells. Retrovirology 2005, 2, e45. [CrossRef]
199. Ducu, R.I.; Dayaram, T.; Marriott, S.J. The HTLV-1 tax oncoprotein represses ku80 gene expression. Virology 2011, 416, 1-8. [CrossRef] [PubMed]
200. Baydoun, H.H.; Pancewicz, J.; Nicot, C. Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. Blood 2011, 117, 5897-5906. [CrossRef] [PubMed]
201. Haoudi, A.; Daniels, R.C.; Wong, E.; Kupfer, G.; Semmes, O.J. Human T-cell leukemia virus-i tax oncoprotein functionally targets a subnuclear complex involved in cellular DNA damage-response. J. Biol. Chem. 2003, 278, 37736-37744. [CrossRef] [PubMed]
202. Park, H.U.; Jeong, J.H.; Chung, J.H.; Brady, J.N. Human T-cell leukemia virus type 1 tax interacts with chk1 and attenuates DNA-damage induced g2 arrest mediated by chk1. Oncogene 2004, 23, 4966-4974. [CrossRef] [PubMed]
203. Gupta, S.K.; Guo, X.; Durkin, S.S.; Fryrear, K.F.; Ward, M.D.; Semmes, O.J. Human T-cell leukemia virus type 1 tax oncoprotein prevents DNA damage-induced chromatin egress of hyperphosphorylated chk2. J. Biol. Chem. 2007, 282, 29431-29440. [CrossRef] [PubMed]
204. Durkin, S.S.; Guo, X.; Fryrear, K.A.; Mihaylova, V.T.; Gupta, S.K.; Belgnaoui, S.M.; Haoudi, A.; Kupfer, G.M.; Semmes, O.J. HTLV-1 tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase. J. Biol. Chem. 2008, 283, 36311-36320. [CrossRef] [PubMed]
205. Chlichlia, K.; Khazaie, K. HTLV-1 tax: Linking transformation, DNA damage and apoptotic T-cell death. Chem Biol Interact 2010, 188, 359-365. [CrossRef] [PubMed]
206. Bellon, M.; Baydoun, H.H.; Yao, Y.; Nicot, C. HTLV-I tax-dependent and -independent events associated with immortalization of human primary t lymphocytes. Blood 2010,115, 2441-2448. [CrossRef] [PubMed]
207. Kumar, P.; Wood, C. Kaposi's sarcoma-associated herpesvirus transactivator rta induces cell cycle arrest in g0/g1 phase by stabilizing and promoting nuclear localization of p27kip. J. Virol. 2013, 87, 13226-13238. [CrossRef] [PubMed]
208. Chini, C.C.; Chen, J. Human claspin is required for replication checkpoint control. J. Biol. Chem. 2003, 278, 30057-30062. [CrossRef] [PubMed]
209. Jarviluoma, A.; Koopal, S.; Rasanen, S.; Makela, T.P.; Ojala, P.M. KSHV viral cyclin binds to p27kip1 in primary effusion lymphomas. Blood 2004, 104, 3349-3354. [CrossRef] [PubMed]
210. Bouchard, M.J.; Schneider, R.J. The enigmatic x gene of hepatitis b virus. J. Virol. 2004, 78, 12725-12734. [CrossRef] [PubMed]
211. Feitelson, M.A.; Zhu, M.; Duan, L.X.; London, W.T. Hepatitis b x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993, 8, 1109-1117. [PubMed]
212. Wang, X.W.; Forrester, K.; Yeh, H.; Feitelson, M.A.; Gu, J.R.; Harris, C.C. Hepatitis B virus x protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ercc3. Proc. Natl. Acad. Sci. USA 1994, 91, 2230-2234. [CrossRef] [PubMed]
213. Lee, S.G.; Rho, H.M. Transcriptional repression of the human p53 gene by hepatitis B viral x protein. Oncogene 2000,19, 468-471. [CrossRef] [PubMed]
214. Rothkamm, K.; Kruger, I.; Thompson, L.H.; Lobrich, M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol. Cell. Biol. 2003, 23, 5706-5715. [CrossRef] [PubMed]
215. Lieber, M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010, 79, 181-211. [CrossRef] [PubMed]
216. Nakamura, H.; Lu, M.; Gwack, Y.; Souvlis, J.; Zeichner, S.L.; Jung, J.U. Global changes in kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible rta transactivator. J. Virol. 2003, 77, 4205-4220. [CrossRef] [PubMed]
217. Hagen, T.M.; Huang, S.; Curnutte, J.; Fowler, P.; Martinez, V.; Wehr, C.M.; Ames, B.N.; Chisari, F.V. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 1994, 91, 12808-12812. [CrossRef] [PubMed]
218. Hsieh, Y.H.; Su, I.J.; Wang, H.C.; Chang, W.W.; Lei, H.Y.; Lai, M.D.; Chang, W.T.; Huang, W. Pre-s mutant surface antigens in chronic Hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 2004, 25, 2023-2032. [CrossRef] [PubMed]
219. Matthews, T.; Boehme, R. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 1988, 10 Suppl. 3, S490-S494. [CrossRef] [PubMed]
220. Ward, I.M.; Chen, J. Histone h2ax is phosphorylated in an atr-dependent manner in response to replicational stress. J. Biol. Chem. 2001, 276, 47759-47762. [CrossRef] [PubMed]
221. Dandri, M.; Burda, M.R.; Burkle, A.; Zuckerman, D.M.; Will, H.; Rogler, C.E.; Greten, H.; Petersen, J. Increase in de novo hbv DNA integrations in response to oxidative DNA damage or inhibition of poly(adp-ribosyl)ation. Hepatology 2002, 35, 217-223. [CrossRef] [PubMed]
222. Leupin, O.; Bontron, S.; Schaeffer, C.; Strubin, M. Hepatitis B virus x protein stimulates viral genome replication via a ddb1-dependent pathway distinct from that leading to cell death. J. Virol. 2005, 79, 4238-4245. [CrossRef] [PubMed]
223. Bresnahan, W.A.; Boldogh, I.; Thompson, E.A.; Albrecht, T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late g1. Virology 1996, 224, 150-160. [CrossRef] [PubMed]
224. Bryan, B.A.; Dyson, O.F.; Akula, S.M. Identifying cellular genes crucial for the reactivation of kaposi's sarcoma-associated herpesvirus latency. J. Gen. Virol. 2006, 87, 519-529. [CrossRef] [PubMed]
225. Becker, S.A.; Lee, T.H.; Butel, J.S.; Slagle, B.L. Hepatitis B virus x protein interferes with cellular DNA repair. J. Virol. 1998, 72, 266-272. [PubMed]
226. Martin-Lluesma, S.; Schaeffer, C.; Robert, E.I.; van Breugel, P.C.; Leupin, O.; Hantz, O.; Strubin, M. Hepatitis B virus x protein affects s phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 2008, 48, 1467-1476. [CrossRef] [PubMed]
227. Jaitovich-Groisman, I.; Benlimame, N.; Slagle, B.L.; Perez, M.H.; Alpert, L.; Song, D.J.; Fotouhi-Ardakani, N.; Galipeau, J.; Alaoui-Jamali, M.A. Transcriptional regulation of the tfiih transcription repair components xpb and xpd by the Hepatitis B virus x protein in liver cells and transgenic liver tissue. J. Biol. Chem. 2001,276, 14124-14132. [PubMed]
228. Prost, S.; Ford, J.M.; Taylor, C.; Doig, J.; Harrison, D.J. Hepatitis b x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes. J. Biol. Chem. 1998, 273, 33327-33332. [CrossRef] [PubMed]
229. Lee, A.T.; Ren, J.; Wong, E.T.; Ban, K.H.; Lee, L.A.; Lee, C.G. The Hepatitis B virus x protein sensitizes hepg2 cells to uv light-induced DNA damage. J. Biol. Chem. 2005, 280, 33525-33535. [CrossRef] [PubMed]
230. Van de Klundert, M.A.; van Hemert, F.J.; Zaaijer, H.L.; Kootstra, N.A. The Hepatitis B virus x protein inhibits thymine DNA glycosylase initiated base excision repair. PLoS ONE 2012, 7, e48940. [CrossRef] [PubMed]
231. Chung, Y.L. Defective DNA damage response and repair in liver cells expressing Hepatitis B virus surface antigen. FASEB J. 2013, 27, 2316-2327. [CrossRef] [PubMed]
232. Wang, W.H.; Hullinger, R.L.; Andrisani, O.M. Hepatitis B virus x protein via the p38mapk pathway induces e2f1 release and atr kinase activation mediating p53 apoptosis. J. Biol. Chem. 2008, 283, 25455-25467. [CrossRef] [PubMed]
233. Zhao, F.; Hou, N.B.; Yang, X.L.; He, X.; Liu, Y.; Zhang, Y.H.; Wei, C.W.; Song, T.; Li, L.; Ma, Q.J. et al. Ataxia telangiectasia-mutated-rad3-related DNA damage checkpoint signaling pathway triggered by Hepatitis B virus infection. World J. Gastroenterol. 2008,14, 6163-6170. [CrossRef] [PubMed]
234. Rakotomalala, L.; Studach, L.; Wang, W.H.; Gregori, G.; Hullinger, R.L.; Andrisani, O. Hepatitis B virus x protein increases the cdt1-to-geminin ratio inducing DNA re-replication and polyploidy. J. Biol. Chem. 2008, 283, 28729-28740. [CrossRef] [PubMed]
235. Studach, L.; Wang, W.H.; Weber, G.; Tang, J.; Hullinger, R.L.; Malbrue, R.; Liu, X.; Andrisani, O. Polo-like kinase 1 activated by the Hepatitis B virus x protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. J. Biol. Chem. 2010, 285, 30282-30293. [CrossRef] [PubMed]
236. Zheng, Z.; Li, J.; Sun, J.; Song, T.; Wei, C.; Zhang, Y.; Rao, G.; Chen, G.; Li, D.; Yang, G.; et al. Inhibition of hbv replication by theophylline. Antiviral Res. 2011, 89, 149-155. [CrossRef] [PubMed]
237. Izumiya, Y.; Lin, S.F.; Ellison, T.J.; Levy, A.M.; Mayeur, G.L.; Izumiya, C.; Kung, H.J. Cell cycle regulation by kaposi's sarcoma-associated herpesvirus k-bzip: Direct interaction with cyclin-cdk2 and induction of g1 growth arrest. J. Virol. 2003, 77, 9652-9661. [CrossRef] [PubMed]
238. Wu, F.Y.; Tang, Q.Q.; Chen, H.; ApRhys, C.; Farrell, C.; Chen, J.; Fujimuro, M.; Lane, M.D.; Hayward, G.S. Lytic replication-associated protein (rap) encoded by kaposi sarcoma-associated herpesvirus causes p21cip-1-mediated g1 cell cycle arrest through ccaat/enhancer-binding protein-alpha. Proc. Natl. Acad. Sci. USA 2002, 99, 10683-10688. [CrossRef] [PubMed]
239. Rodriguez, A.; Jung, E.J.; Flemington, E.K. Cell cycle analysis of epstein-barr virus-infected cells following treatment with lytic cycle-inducing agents. J. Virol. 2001, 75, 4482-4489. [CrossRef] [PubMed]
240. Lilley, C.E.; Chaurushiya, M.S.; Boutell, C.; Everett, R.D.; Weitzman, M.D. The intrinsic antiviral defense to incoming hsv-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein icp0. PLoS Pathog. 2011, 7,e1002084. [CrossRef] [PubMed]
241. FeRNAndez-Capetillo, O.; Chen, H.T.; Celeste, A.; Ward, I.; Romanienko, P.J.; Morales, J.C.; Naka, K.; Xia, Z.; Camerini-Otero, R.D.; Motoyama, N. et al. DNA damage-induced g2-m checkpoint activation by histone h2ax and 53bp1. Nat. Cell Biol. 2002, 4, 993-997. [CrossRef] [PubMed]
242. Machida, K.; Cheng, K.T.; Sung, V.M.; Lee, K.J.; Levine, A.M.; Lai, M.M. Hepatitis C virus infection activates the immunologic (type ii) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J. Virol. 2004, 78, 8835-8843. [CrossRef] [PubMed]
243. Machida, K.; Cheng, K.T.; Lai, C.K.; Jeng, K.S.; Sung, V.M.; Lai, M.M. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and stat3 activation. J. Virol. 2006, 80, 7199-7207. [CrossRef] [PubMed]
244. Nishimura, T.; Kohara, M.; Izumi, K.; Kasama, Y.; Hirata, Y.; Huang, Y.; Shuda, M.; Mukaidani, C.; Takano, T.; Tokunaga, Y. et al. Hepatitis C virus impairs p53 via persistent overexpression of 3beta-hydroxysterol delta24-reductase. J. Biol. Chem. 2009, 284, 36442-36452. [CrossRef] [PubMed]
245. Higgs, M.R.; Lerat, H.; Pawlotsky, J.M. Hepatitis C virus-induced activation of beta-catenin promotes c-myc expression and a cascade of pro-carcinogenetic events. Oncogene 2013, 32, 4683-4693. [CrossRef] [PubMed]
246. Zekri, A.R.; Sabry, G.M.; Bahnassy, A.A.; Shalaby, K.A.; Abdel-Wahabh, S.A.; Zakaria, S. Mismatch repair genes (hmlh1, hpms1, hpms2, gtbp/hmsh6, hmsh2) in the pathogenesis of hepatocellular carcinoma. World J. Gastroenterol. 2005, 11, 3020-3026. [CrossRef] [PubMed]
247. Pal, S.; Polyak, S.J.; Bano, N.; Qiu, W.C.; Carithers, R.L.; Shuhart, M.; Gretch, D.R.; Das, A. Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme neil1. J Gastroenterol Hepatol 2010, 25, 627-634. [CrossRef] [PubMed]
248. Higgs, M.R.; Lerat, H.; Pawlotsky, J.M. Downregulation of gadd45beta expression by Hepatitis C virus leads to defective cell cycle arrest. Cancer Res. 2010, 70,4901-4911. [CrossRef] [PubMed]
249. van Pelt, J.F.; Severi, T.; Crabbe, T.; Eetveldt, A.V.; Verslype, C.; Roskams, T.; Fevery, J. Expression of Hepatitis C virus core protein impairs DNA repair in human hepatoma cells. Cancer Lett 2004, 209, 197-205. [CrossRef] [PubMed]
250. Machida, K.; McNamara, G.; Cheng, K.T.; Huang, J.; Wang, C.H.; Comai, L.; Ou, J.H.; Lai, M.M. Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the atm-nbs1/mre11/rad50 DNA repair pathway in monocytes and hepatocytes. J Immunol 2010,185, 6985-6998. [CrossRef] [PubMed]
251. Ariumi, Y.; Kuroki, M.; Dansako, H.; Abe, K.; Ikeda, M.; Wakita, T.; Kato, N. The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for Hepatitis C virus RNA replication. J. Virol. 2008, 82, 9639-9646. [CrossRef] [PubMed]
252. Lai, C.K.; Jeng, K.S.; Machida, K.; Cheng, Y.S.; Lai, M.M. Hepatitis C virus ns3/4a protein interacts with atm, impairs DNA repair and enhances sensitivity to ionizing radiation. Virology 2008, 370, 295-309. [CrossRef] [PubMed]
253. Bittar, C.; Shrivastava, S.; Bhanja Chowdhury, J.; Rahal, P.; Ray, R.B. Hepatitis C virus ns2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm. PLoS ONE 2013, 8, e62581. [CrossRef] [PubMed]
254. Naka, K.; Dansako, H.; Kobayashi, N.; Ikeda, M.; Kato, N. Hepatitis C virus ns5b delays cell cycle progression by inducing interferon-beta via toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 2006, 346, 348-362. [CrossRef] [PubMed]
255. Wang, Y.; Xu, Y.; Tong, W.; Pan, T.; Li, J.; Sun, S.; Shao, J.; Ding, H.; Toyoda, T.; Yuan, Z. Hepatitis C virus ns5b protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (cinp). J. Biol. Chem. 2011, 286, 26603-26615. [CrossRef] [PubMed]
256. Qadri, I.; Iwahashi, M.; Simon, F. Hepatitis C virus ns5a protein binds tbp and p53, inhibiting their DNA binding and p53 interactions with tbp and ercc3. Biochim. Biophys. Acta 2002, 1592, 193-204. [CrossRef]
257. Luo, M.H.; Rosenke, K.; CzoRNAk, K.; Fortunato, E.A. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (atm)- and atm-rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 2007, 81, 1934-1950. [CrossRef] [PubMed]
258. Levin, A.; Neufeldt, C.J.; Pang, D.; Wilson, K.; Loewen-Dobler, D.; Joyce, M.A.; Wozniak, R.W.; Tyrrell, D.L. Functional characterization of nuclear localization and export signals in Hepatitis C virus proteins and their role in the membranous web. PLoS ONE 2014, 9, e114629. [CrossRef] [PubMed]
259. Chen, Y.; Williams, V.; Filippova, M.; Filippov, V.; Duerksen-Hughes, P. Viral carcinogenesis: Factors inducing DNA damage and virus integration. Cancers 2014, 6, 2155-2186. [CrossRef] [PubMed]
260. Mauser, A.; Holley-Guthrie, E.; Zanation, A.; Yarborough, W.; Kaufmann, W.; Klingelhutz, A.; Seaman, W.T.; Kenney, S. The epstein-barr virus immediate-early protein bzlf1 induces expression of e2f-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells. J. Virol. 2002, 76, 12543-12552. [CrossRef] [PubMed]
261. Mohni, K.N.; Dee, A.R.; Smith, S.; Schumacher, A.J.; Weller, S.K. Efficient herpes simplex virus 1 replication requires cellular atr pathway proteins. J. Virol. 2013, 87, 531-542. [CrossRef] [PubMed]
262. Carpentier, A.; Barez, P.Y.; Boxus, M.; Willems, L. Checkpoints modulation by the human T-lymphotropic virus type 1 tax protein. Retrovirology 2014, 11, e90. [CrossRef]